Alvotech (ALVO) Return on Capital Employed (2023 - 2026)
Alvotech's (ALVO) quarterly Return on Capital Employed came in at 0.42% in Q1 2026, down 499805.0% YoY from N/an in Q1 2025, and down 93.82% on a QoQ basis from 6.84% in Q4 2025.
Alvotech (ALVO) Return on Capital Employed (2023 - 2026) Analysis & Trends
Alvotech (ALVO) has 4 years of Return on Capital Employed data on file, last reported at 0.42% in Q1 2026.
- Quarterly Return on Capital Employed fell 499805.0% year-over-year to 0.42% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.42% (down 499805.0% YoY) and the FY2025 annual result came in at 7.45%, down 36.0% from the prior year.
- Return on Capital Employed retreated to 0.42% in Q1 2026, from 6.84% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 6243.71% in Q1 2024 to a low of 13818.78% in Q1 2023.
- A 4-year average of 198.0% and a median of 0.42% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed jumped 2006249 bps — and 2026, when it sank 499805 bps.
- Tracing ALVO's Return on Capital Employed over 4 years: stood at 73.03% in 2023, then soared by 82 bps to 13.12% in 2024, then jumped by 152 bps to 6.84% in 2025, then plunged by 94 bps to 0.42% in 2026.
- The last three Return on Capital Employed figures came in at 0.42% (Q1 2026), 6.84% (Q4 2025), and 38.39% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Alvotech | 1.23 Bn | 1.23 Bn | 5.09 Mn | 0.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.42% |
| Dec 31, 2025 | 6.84% |
| Sep 30, 2025 | -38.39% |
| Jun 30, 2025 | 12.53% |
| Mar 31, 2025 | 4,998.47% |
| Dec 31, 2024 | -13.12% |
| Sep 30, 2024 | -30.17% |
| Jun 30, 2024 | 533.53% |
| Mar 31, 2024 | 6,243.71% |
| Jun 30, 2023 | -73.03% |
| Mar 31, 2023 | -13,818.78% |